Rhinomed Limited Stock Market Press Releases and Company Profile
to initiate nation wide sleep study this Saturday night
to initiate nation wide sleep study this Saturday night

Melbourne, April 1, 2015 AEST (ABN Newswire) - Rhinomed (googlechartASX:RNO) a Melbourne based sleep and respiratory technology company is pleased to advise that it will initiate a nation wide sleep trial this Saturday night.

The nation wide trial will seek to demonstrate that Australians received an extra one-hour of sleep. The trial will be run in all states except Queensland and Western Australia. All Australians are invited to participate in the trial by registering on the Mutesnoring national sleep trial site Or at mutesnoring.com/national_sleep_trial/ "Sleep is so critical to the way we think, feel and behave. It is vital to our health and Rhinomed is committed to ensuring we help all Australians to sleep better. According to Access Economics poor sleep is costing Australia $5.1 billon annually " said CEO Michael Johnson.

The Mute technology has clearly shown that it can help people to reduce their snoring and improve their sleep. In a five-day in home user trial (n=236) in December 2014 Rhinomed demonstrated that MuteĀ® reduced the incidence of snoring in 75% of users and radically improved sleep quality in both snorers and their partners. With over 60% of Australian households having a snorer, the company has a significant opportunity to improve the lives of millions of Australians.

This weekend the company will clearly show Australians are capable of getting an extra hour of sleep. This trial represents a great opportunity for everyone to rethink how much sleep they're getting and the quality of sleep they need. Ensuring people breathe better at night and reduce their snoring is the first step.

All Australians are invited to trial Mute and experience the benefit of better breathing and more sleep. Mute is available for purchase at your local pharmacy or online at www.mutesnoring.com Rhinomed would also like to remind Australians that they need to put their clocks back this Saturday night as day light savings ends.

About Rhinomed Limited

Rhinomed Limited ASX:RNO

Rhinomed Limited (ASX:RNO) is a Melbourne based technology firm with a focus on nasal, respiratory and breathing management technologies. The company is seeking to monetise applications of its technology portfolio in the Sport, Sleep, Wellbeing and Drug Delivery markets. For more information, go to www.rhinomed.global

TwitterFollow the Turbine on Twitter at @theturbinecom
Follow Mute Snoring on Twitter at @mutesnoring

https://plus.google.com/112881158738803317960 https://twitter.com/rhinomedceo https://www.facebook.com/Rhinomed https://www.youtube.com/channel/UCU_Op9p0A1e4FW5jCPzA2Ww https://www.linkedin.com/company/rhinomed-limited-australia abnnewswire.com 


Contact

Rhinomed Ltd
Michael Johnson, CEO
T: +61-3-8416-0900
F: +61-3-8080-0796
E: mjohnson@rhinomed.com.au
WWW: www.rhinomed.com.au


ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 9) (Last 30 Days: 34) (Since Published: 4763)